Antonia Feola

9PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 15, 2026
Positively Charged Polymers Based on Cyclodextrins for Trametinib and Selumetinib Delivery in Glioblastoma Cancer.

Noemi Bognanni, Maria Teresa Gentile, Antonia Feola

|Jan 15, 2025
CD4+FOXP3Exon2+ regulatory T cell frequency predicts breast cancer prognosis and survival.

Clorinda Fusco, Francesca Di Rella, Antonietta Liotti

|Jan 08, 2025
Sphaeropsidin A Loaded in Liposomes to Reduce Its Cytotoxicity and Preserve Antifungal Activity Against Candida auris.

Annalisa Buonanno, Maria Michela Salvatore, Antonia Feola

|Jan 11, 2024
Polystyrene Microplastics Exacerbate Candida albicans Infection Ability In Vitro and In Vivo.

Angela Maione, Mariangela Norcia, Marica Sinoca

|Jul 29, 2023
Effect of Escin Alone or in Combination with Antifungal Agents on Resistant Candida glabrata Biofilms: Mechanisms of Action.

Angela Maione, Marianna Imparato, Marilena Galdiero

|Jun 28, 2023
Specific Methyl-CpG Configurations Define Cell Identity through Gene Expression Regulation.

Teresa Improda, Valentina Morgera, Maria Vitale

Pageof 2